跳至主要内容
临床试验/CTRI/2025/12/099346
CTRI/2025/12/099346尚未招募3 期

CLINICAL STUDY TO EVALUATE THE EFFICACY OF SHITKALYANAKA GHRITA IN THE MANAGEMENT OF ARTAVAKSHAYA W.S.R TO OLIGOMENORRHEA.

Dr. Heena1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年12月26日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
Improvement in amount of menstrual blood

研究概览

简要总结

The condition characterized with very scanty menstrual bleeding.

Artavakshaya is not a disease but a symptom of various underlaying health conditions. however depending on the etiopathogenesis Artavakshaya occurs due to Dosha has obstruct the passage or orifice of channels

carrying Artava thus Artava is destroyed. their are several drug of Artavakshaya but here I have chosen SHITKALYANAKA GHRITA which not only treats symptoms but also does samprapti bhanga.

Therefore I have selected 40  patients aged between 18-40 years, patients should be selected on the basis of inclusion and exclusion criteria. The trial will be of 3 consecutive months and follow up will be done after each months. Cured after 3 months patient gets 80-100percent rellef from sign and symptoms.

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 40.00 Year(s)(—)
性别
Female

入选标准

  • Age group 18 to 40 years.
  • Interval between two menstrual cycles is greater than 35 days (for the last three months approximately).
  • Duration of menstrual flow is two days or less (for the last three months approximately).
  • Patients complaining of alpartava and yonishool.
  • Pain during menses.

排除标准

  • Patients below age of 18 years and above age of 40 years.
  • Positive history of venereal diseases (HIV, HBsAg, anti HCV, VDRL, HPV etc.)
  • Patient having congenital anomalies and structural defect in female genital
  • Patient having chronic systemic disease like DM , cardiac vascular disease.

结局指标

主要结局

Improvement in amount of menstrual blood

时间窗: 3 month | the trail drug will be given for 3 months with anupana and follow up will be done after every menstrual cycle

次要结局

  • improvement in duration of menstrual bleeding and interval between two cycles(after analyzing all the parameters the result will be assessed on the basis of symptomatic relief and improvement.)

研究者

发起方
Dr. Heena
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Heena

Jeevan Jyoti Ayurvedic Medical College & Hospital

研究点 (1)

Loading locations...

相似试验